title: TNF-alpha is involved in the mechanism of murine thymic lymphoma prevention by bone marrow grafting.
authors.affiliation: University of Liège, Department of Pathology, CHU B35, Belgium.
authors.forename: C
authors.initials: C
authors.lastname: Humblet
authors.forename: J
authors.initials: J
authors.lastname: Deman
authors.forename: A M
authors.initials: AM
authors.lastname: Rongy
authors.forename: R
authors.initials: R
authors.lastname: Greimers
authors.forename: J
authors.initials: J
authors.lastname: Boniver
authors.forename: M P
authors.initials: MP
authors.lastname: Defresne
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation; D002454:Cell Differentiation / Q000187:drug effects; D018450:Disease Progression; D004848:Epithelium / Q000187:drug effects / Q000502:physiology / Q000528:radiation effects; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D016131:Lymphocyte Subsets / Q000473:pathology; D008223:Lymphoma / Q000209:etiology / Q000517:prevention & control*; D051379:Mice; D008810:Mice, Inbred C57BL; D009381:Neoplasms, Radiation-Induced / Q000517:prevention & control*; D011289:Preleukemia / Q000209:etiology / Q000473:pathology / Q000628:therapy; D011828:Radiation Chimera; D011994:Recombinant Proteins / Q000494:pharmacology; D013950:Thymus Gland / Q000473:pathology / Q000528:radiation effects; D013953:Thymus Neoplasms / Q000209:etiology / Q000517:prevention & control*; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology / Q000627:therapeutic use*; D014916:Whole-Body Irradiation / Q000009:adverse effects*
chemical_list: D007155:Immunologic Factors; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha